Steven O'Reilly

19PUBLICATIONS
3CO-AUTHORS
Molecular medicineInnate immunityGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Energy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 03, 2025
The metabolic drivers of IFN-γ release: glycolysis and acetyl CoA ride in the front seat.

John Henderson, Steven O'Reilly

|Feb 22, 2024
Emerging therapeutic targets in systemic sclerosis.

Steven O'Reilly

|Sep 19, 2023
Interleukin-11 and its eminent role in tissue fibrosis: a possible therapeutic target.

Steven O'Reilly

|May 16, 2023
Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets.

S O'Reilly

|Jul 21, 2022
Toll-like receptor triggering in systemic sclerosis: time to target.

Steven O'Reilly

Pageof 4